ClinicalTrials.Veeva

Menu

Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI (Lipid-PCI)

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Coronary Artery Disease
Hyperlipidemias

Treatments

Drug: LDL reduction therapy

Study type

Observational

Funder types

Other

Identifiers

NCT06338956
Lipid-PCI

Details and patient eligibility

About

For the management of low-density lipoprotein-cholesterol (LDL-C), some guidelines recommend initial statin treatment with high-intensity statins to achieve at least a 50% reduction in LDL-C levels. High-intensity or maximally tolerated intensity can be maintained without a target goal. However, the European guideline recommends less than 55 mg/dL of LDL-C after PCI.

Full description

To investigate the Optimal Attained LDL-C Levels in Patients Who Achieved ≥50% LDL-C Reduction After PCI.

Enrollment

135,877 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients receiving PCI with health check up before and after PCI within 3 years

Exclusion criteria

  • Patients receiving statin before PCI
  • Patients with liver cirrhosis
  • Patients with cancer
  • Patients without prescription of statin
  • Patients with LDL-C <55 mg/dL before PCI

Trial design

135,877 participants in 2 patient groups

>=50% LDL-C reduction
Description:
LDL-C reduction \>=50% Further divided by LDL \<55mg/dL 55\< LDL \< 70 mg/dL LDL \> 70 mg/dL
Treatment:
Drug: LDL reduction therapy
<50% LDL-C reduction
Description:
LDL-C reduction \<50%
Treatment:
Drug: LDL reduction therapy

Trial contacts and locations

1

Loading...

Central trial contact

Danbee Kang, PhD; Ki Hong Choi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems